One mutation every day

Ravages in a lung cancer genome

One mutation every day

lung-cancer-cells.jpgAnne Weston, LRI, CRUK, Wellcome Images
Lung cancer cell dividing. The two daughter cells are only held together by a very thin bridge of cytoplasm.

Research published in Nature shows that the genome of a lung cancer patient has more than 20,000 mutations: this total implies that a typical smoker would acquire one mutation for every 15 cigarettes smoked. The cancer genome is ravaged by mutations, many of which are repaired as the genome tries to defend itself.

In many cases, that battle is lost and some of the many thousands of mutations hit key genes and lead to cancer.

In the study, the researchers compared the genomes in normal blood cells and tumour cells from a patient with small cell lung cancer (SCLC). They sequenced the genome a total of 60 times over to develop a comprehensive catalogue of all known types of DNA mutation.

"For the first time, we have a comprehensive map of all mutations in a cancer cell. The profile of mutations we observed is exactly that expected from tobacco, suggesting that the majority of the 23,000 we found are caused by the cocktail of chemicals found in cigarettes. On the basis of average estimates, we can say that one mutation is fixed in the genome for every 15 cigarettes smoked."

Dr Peter Campbell, senior author on the work, from the Cancer Genome Project at the Wellcome Trust Sanger Institute

The mutations range from single-letter changes in the code to deletions or rearrangements of hundreds of thousand of letters. Most are 'passenger' mutations, previously defined by the team as mutations that do not influence the development of the cancer, but are a consequence of the highly mutagenic environment in many cancer cells.

"Cancers occur when control of cell behaviour is lost - cells grow how, when and where they shouldn't. Mutations in DNA caused by, for example, cigarette smoke are passed on to every subsequent generation of daughter cells, a permanent record of the damage done. Like an archaeologist, we can begin to reconstruct the history of the cancer clone - revealing a record of past exposure and accumulated damage in the genome."

Dr Andy Futreal from the Wellcome Trust Sanger Institute

The study was so comprehensive that the team could see signatures of an undiscovered system of DNA repair, reducing the mutations in highly active genes, suggesting the genome seeks to preserve these regions above many others.

However, as previous studies suggested, there was not one mutation that stood out as 'the lung cancer gene'. One gene - CHD7 - was found to be mutated in several SCLC samples. This gene is part of an emerging pattern that cancers often contain mutations in genes that are generalists in regulating genetic activity alongside more specific changes.

This work and the companion study on malignant melanoma using massively parallel sequencing portend an era in which the forces of mutagens shaping our genome can be described and the consequences of these processes can be decoded.

It is clear that rates of lung cancer fall to around normal some 15 years after quitting smoking: the suspicion is that lung cells containing mutations are replaced by new cells derived from lung stem cells that are clear of mutation.

"This is a difficult disease to diagnose and treat, but fortunately we do know how people can minimize their risk of lung cancer. Even current smokers substantially reduce their risk by giving up now - the more time passes off tobacco, the more the risk decreases."

Professor Mike Stratton, Sanger Institute

Notes and statistics

Globally, lung cancer claims more than one in six cancer deaths each year. Of the two major types, small cell lung cancer is found in 15 per cent of cases, but has much the worse prognosis, with only one in 20 patients surviving for five years.

Cancer of the respiratory tract (lung, trachea, bronchus) is the most common cause of death from cancer in Europe and the USA.
WHO global infobase

Notes to Editors
  • A small-cell lung cancer genome with complex signatures of tobacco exposure.

    Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A et al.

    Nature 2010;463;7278;184-90


This work was supported by the Wellcome Trust. Support for individual researchers was from the Kay Kendall Leukaemia Fund, Human Frontiers Science Program and the National Cancer Institute.

Selected Websites
Contact the Press Office

Emily Mobley, Media Manager

Tel +44 (0)1223 496 851

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Dr Matthew Midgley, Media Officer

Tel +44 (0)1223 494 856

Wellcome Sanger Institute,
CB10 1SA,

Mobile +44 (0) 7748 379849

Recent News

Researchers identify new possibilities for the treatment of inflammatory bowel disease
Two molecular pathways found to be integral to maintaining balance in the digestive system
Root of childhood kidney cancer discovered
Pre-cancerous signatures found in healthy tissue point the way towards new treatment options
From childhood cancer to mapping human development: Pioneering scientist awarded 2019 Foulkes Foundation medal
Congratulations to Professor Muzlifah Haniffa, who has been recognised for her work on the immune system and childhood cancer